Features interviews and dialogues with venture companies supported by KII.
New determination of a listed innovative drug discovery venture
Interview: Kringle Pharma President and CEO Kiichi Adachi x KII Yukatsu Hongo
Accelerating Computational Science and Technology and Drug Discovery Horizon
Interview: Shun Kimura, CEO of Modulus Discovery, Inc.
Whereabouts of the vision to make human beings healthy from "eyes"
Interview: Kazuo Tsubota, President and CEO of Tsubota Laboratory, Inc.
A new market for data business facing "space x communication"
Interview: Skygate Technologies CEO Awanori Awazu
The lives of people saved by the world's first "3D printed artificial limbs"
Interview: Yasushi Tokushima, CEO of Instalimb, Inc.
A new relationship between pets and humans guided by a sense of mission
Interview: 25 Holdings Co-founder Hideki Fujita
A new era of diagnostic imaging with light and ultrasound
Interview: Luxonus CEO Sadakazu Aiso & CTO Takayuki Yagi
Future forecast of the economy pioneered by AI
Interview: xenodata lab. CEO Yojiro Seki
Future light pioneered by iPS cells x corneal transplantation
Interview: CEO of Selujon Shin Hato
The world's first future revolution led by "all resin batteries"
Interview: APB CEO Hideaki Horie
Prospects for antibody drugs that will revolutionize cancer immunotherapy
Interview: IDAC Seranostics President and CEO Satoshi Ito
New innovations in regenerative medicine that challenge with unique technology
Interview: Hiroshi Miyazaki, President and CEO of AdipoSeeds & Yumiko Matsubara, MD
A new era of education and human resource utilization realized by AI support
Interview: Masahiro Fukuhara, President and CEO of IGS (Institution for a Global Society)
Innovative technology from Japan that gives machines a "tactile sensation"
Interview: Motion Rib President and CEO Takahiro Mizoguchi
The future of "data utilization" that eliminates waste and creates value
Interview: Ryosuke Konishi, President and CEO of General Solutions
New innovations in earphone-type wearable devices from Japan
Interview: BONX CEO Takahiro Miyasaka
Impact of "treatment app" that overturns common sense in medical treatment
Interview: CureApp President and CEO Kota Satake
A vision of diversity led by "AI that learns sense"
Interview: SENSY CEO Yuki Watanabe
Hope for the future drawn with the world's only drug discovery technology
Interview: Kringle Pharma CEO Kiichi Adachi
For a future where people and businesses are more “connected”
Interview: Quon CEO Takashi Takeda